Figure 1.

Cascades of HCV care in the overall cohort from 8/2021 through 8/2022, stratified by inpatient initiation of antivirals. Legend: *2 censored — linked to local providers. ^~1 censored — died during week 7/8 from cause unrelated to treatment. ^1 patient completed only 4/8 weeks of therapy but achieved SVR8. ⁺1 patient completed only 1/8 weeks due to medical event unrelated to treatment precluding continuation but had an undetectable RNA > 12 weeks later